Case Study | October 02, 2008 | Suhny Abbara, M.D., assistant professor, Harvard Medical School, director, Cardiovascular Imaging, M

Biphasic Injection Protocol – Optimized for Coronary Artery Imaging


This case is a routine coronary CTA with the focus on the coronary arteries. The patient was a middle-aged male with a family history of coronary artery disease, moderate risk profile and atypical chest pain. The EKG did not indicate myocardial ischemia and there was no enzyme leak. The referring physician was considering invasive angiography to definitely exclude coronary artery disease as the cause of the atypical chest pain. Due to concerns regarding the invasiveness of the procedure and a relatively low likelihood that coronary artery disease was present, a cardiac gated 64-slice coronary MDCT angiogram was performed instead.
The contrast injection protocol in this study is tailored to opacify the coronary arteries during the MDCT acquisition and to wash out the right atrium and ventricle with a saline chaser bolus.
The latter is desired for two reasons. First, if contrast were to remain in the right heart during acquisition, streak artifact may result in image degradation, potentially decreasing the evaluability of the mid-RCA. The streak artifact occurs because of the mixing of relatively dense contrast containing blood from the superior vena cava with in-flowing, non-opacified blood from the inferior vena cava. Secondly, if contrast material is located in the right heart during the scan acquisition, it obviously cannot contribute to the opacification of the coronary arteries — the structures of interest. A higher contrast volume at a higher rate, therefore, would be necessary to achieve the same opacification as in a patient with washed out right heart and optimal contrast timing.
Because the image quality in this case is excellent and the negative predictive value of coronary CTA in research studies is typically between 95 and 100 percent, it could be established that in this patient the chest symptoms were unrelated to coronary artery disease. The patient was spared the invasive angiogram.


Related Content

News | Contrast Media

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

Home August 17, 2023
Home
News | Contrast Media

July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Home July 03, 2023
Home
News | Contrast Media

May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE ...

Home May 11, 2021
Home
Technology | Contrast Media

July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic ...

Home July 15, 2019
Home
Videos | Contrast Media

Sharon Mulvagh, M.D., FASE, FACC, FRCPC, professor of medicine, division of cardiology, Dalhousie University, Halifax ...

Home June 28, 2019
Home
Feature | Contrast Media | Dave Fornell, Editor

Iodine-based contrast agents used in computed tomography (CT) and catheter-based angiography have been implicated as a ...

Home May 31, 2019
Home
News | Contrast Media

May 9, 2019 — Osprey Medical announced the launch of DyeMINISH, a global patient registry to evaluate the ongoing safety ...

Home May 09, 2019
Home
News | Contrast Media

November 30, 2018 — VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that ...

Home November 30, 2018
Home
News | Contrast Media

In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore ...

Home September 12, 2018
Home
News | Contrast Media

January 19, 2018 — Ligand Pharmaceuticals Inc. announced initiation of a program to develop contrast agents with reduced ...

Home January 19, 2018
Home
Subscribe Now